13 analysts have expressed a variety of opinions on Edwards Lifesciences (NYSE:EW) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 3 | 6 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 2 | 5 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.23, a high estimate of $107.00, and a low estimate of $85.00. Surpassing the previous average price target of $90.75, the current average has increased by 6.04%.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of Edwards Lifesciences by financial experts...
Login or create a forever free account to read this news
Sign up/Log in